Saturday 17 October 2026
Export CRKN’s income statement to Excel — free account
Crown Electrokinetics Corp.
CRKN Basic Materials Specialty Chemicals
Crown Electrokinetics Corp.’s revenue for fiscal 2024 (year ended December 2024) was $19.7 million, up 12,776.5% from fiscal 2023. In the quarter to March 2025, revenue grew 306.5%, EPS grew 99.8% and free cash flow fell 362.5%, each against the same quarter a year earlier. Revenue growth for three consecutive years.
0.00
0.01
−100.00%
Follow CRKN
| Older periods | Jun '24 | Sep '24 | Dec '24 | Mar '25 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
1.55 | 0.43 | 64.12 | 0.21 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(1.37) | (1.98) | (196.78) | (0.42) | |
P/B ratio |
0.96 | 0.58 | 56.79 | 0.13 | |
Price to Tangible BV |
1.13 | 0.66 | 59.91 | 0.13 | |
EV/Sales |
0.87 | 0.22 | 63.46 | (0.79) | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.62 | |
EV/Operating CF |
(0.29) | (0.18) | (68.76) | 0.65 | |
EV/FCF |
(0.26) | (0.15) | (51.39) | 0.50 | |
Quick Ratio |
1.28 | 1.27 | 1.72 | 4.47 | |
Current Ratio |
1.60 | 1.40 | 2.13 | 5.11 | |
Net Debt/EBITDA |
0.81 | 0.54 | 1.48 | 2.36 | |
Debt/Assets |
1.85% | 1.76% | 1.94% | 1.42% | |
Debt/Equity |
0.03 | 0.03 | 0.03 | 0.02 | |
Asset Turnover |
0.39 | 0.90 | 0.89 | 0.83 | |
Operating CF/Net income |
0.60 | 0.50 | 0.56 | 1.14 | |
Capex/Depreciation |
0.02 | (3.18) | (4.55) | (2.49) | |
Interest Coverage |
(33.85) | — | 881.82 | 50.00 | |
Research and Development Expense of Revenue |
23.90% | 8.96% | 10.07% | 43.98% | |
Selling, General and Administrative Expense of Revenue |
90.08% | 80.96% | 119.47% | 276.48% | |
Intangible Assets out of Total Assets |
0.08 | 0.07 | 0.03 | 0.03 | |
Share Based Compensation of Revenue |
46.26% | 26.79% | 10.63% | 76.26% | |
Graham Net Nets |
0.23 | 0.18 | 0.01 | 5.15 | |
Graham Number |
91,994.10 | 61,109.92 | 0.00 | 1,044.42 | |
Earnings Yield |
69,309.30% | 282,850.01% | (2,953.22%) | 82,191.16% | |
Free Cash Flow Yield |
(214.50%) | (335.68%) | (1.93%) | (744.82%) | |
Revenue per Share |
397.27 | 257.60 | 0.11 | 1.66 | |
Operating CF per Share |
(527.86) | (93.24) | (0.11) | (6.58) | |
Capex per Share |
0.60 | (66.25) | (0.07) | (0.99) | |
Free Cash Flow per Share |
(527.26) | (159.49) | (0.18) | (7.58) | |
Cash per Share |
341.03 | 98.94 | 0.23 | 13.42 | |
Shareholders Equity per Share |
750.60 | 318.04 | 0.38 | 21.45 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
750.60 | 318.04 | 0.38 | 21.45 | |
Free Cash Flow |
(6.17) | (4.98) | (10.44) | (12.67) | |
Working Capital |
3.43 | 2.49 | 12.51 | 25.19 | |
Capital Expenditures |
0.01 | (2.07) | (4.02) | (1.66) | |
Net Current Asset Value |
1.96 | 1.05 | 10.85 | 23.70 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.57 | |
Capex to Sales |
0.00 | 0.26 | 0.64 | 0.60 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
1.69 | 2.54 | 2.72 | 2.86 | |
Average Payables |
2.02 | 3.10 | 3.47 | 2.92 | |
Average Assets |
14.07 | 14.90 | 22.26 | 26.18 | |
Average Common Equity |
6.67 | 9.60 | 13.46 | 19.10 |
Columns are period end dates